Along with the suppression of anti-tumor immunity, myeloid cells produce inflammatory cytokines (IL-23, IL-6, IL-1) that drive the expansion and activation of pro-tumorigenic T helper 17 (Th17) cells [78,79]. This evidence concerns the gene IL1B and neoplasm.